NCT05854303Recruiting

Effect of Opioid Cessation on Opioid-Induced Esophageal Dysfunction

Mayo Clinic

Start Date

9/18/2023

Completion Date

11/1/2026

Summary

The purpose of this study is to evaluate the effect of opioid cessation on opioid-induced esophageal dysfunction (OIED).

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: \- Patients enrolled in the Pain Rehabilitation Center for opioid cessation, with or without esophageal symptoms. Exclusion Criteria: * Inability to provide informed consent. * Patients with previous gastroesophageal surgery or pneumatic dilation. * Esophageal botulinum toxin injection within the prior 12 months. * Esophageal stricture * Achalasia types I and II * Allergy to Lidocaine or other local anesthetics * Subjects on anticoagulation * Bilateral nasal obstruction * Pregnancy or breast feeding

Interventions

BEHAVIORAL

Opioid cessation

OTHER

No opioid cessation

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Opioid-Induced Esophageal Dysfunction

Locations

Mayo Clinic Minnesota

Rochester, Minnesota 55905

United States